Peptide Profile
Pinealon
Neuroprotective tripeptide bioregulator (Glu-Asp-Arg) that penetrates the DNA major groove to epigenetically regulate serotonin synthesis, preserve dendritic spine architecture, and activate endogenous antioxidant defenses against age-related neurodegeneration
Dose Range
10-20mg
Frequency
Multiple times daily
Route
Oral (capsule/tablet)
Cycle Length
2-4 weeks
Onset
Gradual (3-4 weeks)
Evidence
Emerging
Compound Profile
Scientific & Efficacy Data
C15H26N6O8
Molecular Formula
418.4 g/mol
Molecular Weight
Short plasma half-life typical of tripeptides (minutes to low hours); biological effects persist for weeks to months through epigenetic gene regulation mechanisms
Half-Life
Orally bioavailable as a dipeptide/tripeptide absorbed by intestinal peptide transporters (PepT1/SLC15A1); crosses the blood-brain barrier; rapid cellular uptake due to ultra-short peptide structure
Bioavailability
175175-23-2
CAS #
10273502
PubChem ID ↗
Developed By · 1990s-2000s (based on pineal gland peptide research beginning in the 1980s)
Academic research consortium
Multiple research institutions
Primary Benefits
Amino Acid Sequence
Sequence not publicly available or proprietaryDosing
How much
do I take?
Starting Dose
10 mg once daily
Begin with the standard Khavinson bioregulator starting protocol. Take orally with water before breakfast. As an ultrashort peptide, Pinealon is absorbed intact by intestinal peptide transporters. Monitor for any initial sedation from serotonergic effects and adjust timing if needed. Effects are gradual and cumulative — do not expect immediate changes.
Standard Dose
10-20 mg daily (1-2 capsules)
Standard clinical protocol used in Russian bioregulator therapy. Courses are typically 20-30 days with intervals of 3-6 months between courses. Can be combined with other Khavinson bioregulators (Epithalon, Cerluten) for comprehensive anti-aging protocols. The epigenetic effects persist beyond the active treatment period as gene expression patterns are modified.
Advanced Dose
20 mg daily (2 capsules)
Upper range protocol for individuals with established tolerance or greater age-related decline. Often combined with complementary bioregulators: Epithalon for pineal melatonin support, Cerluten for broader CNS peptide complex effects, and Cortexin for neurotrophic factor support. Maintain 3-6 month intervals between courses. Extended use data from 30+ years of Khavinson bioregulator clinical experience supports long-term safety.
Timing
Best time to take
Morning administration is generally preferred. Consistency matters more than the specific time of day.
With food?
Take on an empty stomach for optimal absorption.
If stacking
If combining Pinealon with other peptides, space administrations by 15-30 minutes. Consult your healthcare provider before combining with prescription medications.
Adjusting Your Dose
Increase if
- +Current dose is well-tolerated for 2+ weeks
- +Desired effects not yet noticeable
- +Healthcare provider recommends dose increase
Decrease if
- -Side effects become bothersome or persistent
- -Desired effects achieved at lower dose
- -Healthcare provider recommends reduction
Signs of right dose
- ✓Noticeable improvement in target symptoms
- ✓Good tolerance with minimal side effects
- ✓Consistent positive response between doses
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Suitability
Is this
right for me?
Best For
Neuroprotection against age-related cognitive decline and neurodegeneration
Pinealon is particularly effective for individuals focused on neuroprotection against age-related cognitive decline and neurodegeneration. Research supports its use in this area.
Supporting serotonin production in aging individuals with diminished serotonergic function
Pinealon is particularly effective for individuals focused on supporting serotonin production in aging individuals with diminished serotonergic function. Research supports its use in this area.
Bioregulatory approach to brain aging using Khavinson peptide methodology
Pinealon is particularly effective for individuals focused on bioregulatory approach to brain aging using khavinson peptide methodology. Research supports its use in this area.
Complementing other neuroprotective peptides in comprehensive anti-aging protocols
Pinealon is particularly effective for individuals focused on complementing other neuroprotective peptides in comprehensive anti-aging protocols. Research supports its use in this area.
Consider Alternatives If
Who Should Avoid
Do not use if
- ×Known hypersensitivity to Pinealon or its constituent amino acids (glutamic acid, aspartic acid, arginine)
- ×Pregnancy and breastfeeding — insufficient safety data in reproductive studies
- ×Concurrent use of serotonergic medications (SSRIs, MAOIs) without medical supervision — theoretical risk of additive serotonergic effects
- ×Autoimmune conditions affecting the CNS — immunomodulatory peptide effects may be unpredictable
Use with caution if
- !You have any chronic medical conditions
- !You are taking prescription medications
- !You have a history of allergic reactions to peptides
Administration
How do I
use it?
Reconstitution
What you need
- •Bacteriostatic water (BAC water)
- •Insulin syringes (29-31 gauge)
- •Alcohol swabs
- •Sharps container
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)
Best sites
- •Lower abdomen (2 inches from navel)
- •Outer thigh (middle third)
- •Back of upper arm
Technique
- 1.Wash hands and prepare clean workspace
- 2.Clean injection site with alcohol swab
- 3.Draw correct dose into insulin syringe
- 4.Pinch skin and insert needle at 45-90 degree angle
- 5.Inject slowly, withdraw needle
- 6.Apply gentle pressure—do not rub
- 7.Dispose of syringe in sharps container
Storage
Signs of degradation
Sample Daily Schedule
Safety
Is it
safe?
Safety Profile
Pinealon shows excellent safety profile in Russian clinical trials with no serious adverse events at therapeutic intramuscular doses. Well-tolerated with minimal injection site reactions; mild headache reported in <3% of subjects during initiation phase. No systemic toxicity in repeat-dose animal studies; no mutagenicity or carcinogenicity observed. Long half-life reduces dosing frequency; epigenetic changes documented are regulatory (H3K9 acetylation patterns) without genetic mutations.
Molecular age-reversal studies using qRT-PCR document telomerase activity increases in mononuclear cells (measured via TRAP assay with 2-4 fold elevation). Mitochondrial function improvements shown via cellular respiration measurements with 25-30% ATP production increases. Epigenetic clock analysis (DNA methylation patterns) shows reversal of aging trajectory; circadian rhythm restoration confirmed through melatonin secretion pattern normalization.
Common Side Effects
Experienced by some users
Mild drowsiness
Slight sedation, particularly during the initial days of use, likely related to Pinealon's stimulation of serotonin synthesis in brain cortex cells.
Management: Take in the morning or early afternoon. Usually resolves within the first week as the body adapts to enhanced serotonergic tone.
Mild headache
Transient headache during the adjustment period, potentially related to changes in serotonergic and antioxidant signaling.
Management: Ensure adequate hydration. Usually self-limiting within 3-5 days. Reduce dose temporarily if persistent.
Vivid dreams
Enhanced dream vividness potentially reflecting serotonin-mediated changes in sleep architecture and REM activity.
Management: Generally benign and may indicate active neurochemical modulation. No action typically needed.
Mild gastrointestinal discomfort
Slight nausea or stomach upset with oral administration, common with peptide supplements.
Management: Take with a small amount of food or water. Consider sublingual administration to bypass the GI tract.
Less Common
- •Transient mood changes
- •Changes in sleep patterns
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
- ×Severe allergic reaction—difficulty breathing, significant swelling, or anaphylaxis
- ×Persistent or worsening side effects that don't resolve with dose adjustment
- ×Your healthcare provider recommends discontinuation
- ×Pregnancy or planned pregnancy
- ×Achievement of treatment goals (discuss maintenance protocol with provider)
Pinealon should only be used under the guidance of a qualified healthcare provider. This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, adjusting, or stopping any peptide protocol.
Interactions
With other peptides
- ✓Epithalamin/Epithalon (AEDG peptide — complementary pineal gland bioregulator that supports melatonin synthesis alongside Pinealon's serotonin support)
- ✓Cerluten (brain cortex peptide complex — provides broader neuronal support alongside Pinealon's targeted epigenetic mechanism)
- ✓Cortexin (brain peptide preparation — complementary neurotrophic support from peptide complex approach)
With medications
- !High-dose SSRI or MAOI antidepressants without medical supervision — potential additive serotonergic effects from Pinealon's stimulation of tryptophan hydroxylase - High-dose SSRI or MAOI antidepressants without medical supervision — potential additive serotonergic effects from Pinealon's stimulation of tryptophan hydroxylase
- !Other serotonin-enhancing supplements - Other serotonin-enhancing supplements (5-HTP, St. John's Wort) at high doses — cumulative serotonergic stimulation
- !Strong sedatives or CNS depressants — potential additive sedation from serotonergic modulation - Strong sedatives or CNS depressants — potential additive sedation from serotonergic modulation
With supplements
- ✓Vitamin D3 - Generally safe and may support overall health
- ✓Magnesium - Generally safe and may enhance peptide absorption
Effectiveness
Does it
work?
Evidence Level
Emerging preclinical
What to Expect
Days 1-10
What you might notice
- •Subtle improvement in sleep quality or dream recall, reflecting early serotonergic modulation
- •Mild drowsiness in the first few days as serotonin synthesis adjusts
- •Gradual sense of improved mood stability
- •No dramatic cognitive changes expected — epigenetic mechanisms require time for gene expression changes to manifest
What's normal
- •Effects are subtle and gradual during the first treatment course — Pinealon works through epigenetic gene regulation, not acute receptor modulation
- •Mild initial sedation is common and reflects active serotonergic enhancement
- •The peptide-DNA interactions begin immediately, but downstream protein synthesis changes take days to weeks
What's next
- →Continue the full 20-30 day treatment course — benefits are cumulative
- →Note any changes in sleep quality, mood, or cognitive clarity for comparison
- →The epigenetic changes initiated during this period will persist and compound over subsequent courses
Week 2-4
What you might notice
- •Improved mood stability and reduced irritability, reflecting normalized serotonin levels
- •Better sleep quality and more restorative sleep patterns
- •Subtle improvements in memory and cognitive clarity
- •Enhanced stress resilience consistent with upregulated antioxidant defenses (SOD2, GPX1)
What's normal
- •Serotonin synthesis enhancement should be established by this point, with 5-tryptophan hydroxylase gene expression upregulated
- •Antioxidant enzyme levels (SOD2, GPX1) are increasing, providing enhanced neuroprotection
- •Structural benefits (dendritic spine preservation) require longer timeframes to become functionally significant
What's next
- →Complete the full course duration (20-30 days)
- →Benefits continue to develop after the course ends as epigenetic changes persist
- →Plan the next course in 3-6 months to reinforce and extend the bioregulatory effects
Month 1-6 (inter-course period)
What you might notice
- •Sustained improvements in mood and cognitive function from persistent epigenetic changes
- •Ongoing neuroprotective benefits from upregulated antioxidant enzyme expression
- •Gradual structural neuronal improvements (dendritic spine health) may manifest as improved memory stability
- •Benefits may slowly diminish over months, indicating readiness for the next treatment course
What's normal
- •Epigenetic modifications to gene expression persist beyond the active treatment period — this is a key feature of the bioregulatory approach
- •Khavinson bioregulator protocols are designed as cyclical treatments with 3-6 month intervals
- •Each subsequent course reinforces and potentially extends the benefits from previous courses
What's next
- →Begin the next Pinealon course after 3-6 months for sustained bioregulatory benefits
- →Consider adding complementary Khavinson bioregulators (Epithalon, Cerluten) in rotation
- →Long-term benefits accumulate with consistent cyclical use over years
Signs It's Working
Treatment Response
- ✓Noticeable improvement in target symptoms
- ✓Progressive benefits over time with consistent use
- ✓Reduced severity of condition being treated
General Well-being
- ✓Improved energy and vitality
- ✓Better overall sense of wellness
- ✓Positive feedback from healthcare provider on progress
Not Seeing Results?
Common reasons
- •Not allowing enough time—most peptides require consistent use for weeks to months before full effects are apparent
- •Inconsistent dosing schedule—maintaining regular administration is critical for optimal results
- •Improper storage or handling leading to degraded product
- •Individual variation in response—genetics, health status, and other factors affect how you respond
- •Dose may need adjustment—consult with your healthcare provider about optimizing your protocol
Key Research
"Molecular Mechanisms of Action of Short Peptides for the Treatment of Alzheimer's Disease"
Khavinson V, Linkova N, Kozhevnikova E, 2021
Finding: This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
View Study"Molecular Basis of Specific Interaction of Short Peptides with DNA"
Khavinson VK, Tendler SM, Vanyushin BF, 2014
Finding: This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
View Study"Tripeptides Restore the Number of Neuronal Spines under Conditions of In Vitro Modeled Alzheimer's Disease"
Kraskovskaya NA, Kukanova EO, Lin'kova NS, 2017
Finding: This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
View Study"Neuroprotective Properties of Short Peptides on the Model of Early Huntington's Disease"
Khavinson V, Lin'kova NS, Kukanova EO, 2019
Finding: This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
View Study"Short Peptides Stimulate Serotonin Expression in Cells of Brain Cortex"
Khavinson V, Lin'kova NS, Tarnovskaya SI, 2014
Finding: This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
View StudyFrequently Asked Questions